l-697661 has been researched along with AIDS Seroconversion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davey, RT; Dewar, RL; Falloon, J; Haneiwich, SE; Kovacs, JA; Masur, H; Polis, MA; Reed, GF; Vasudevachari, MB; Walker, RE | 1 |
Blaschke, T; Campbell, TB; Collier, A; Kahn, J; Kuritzkes, DR; Messari, F; Phair, J; Pottage, JC; Rosandich, ME; Schooley, RT; Stein, DS | 1 |
2 trial(s) available for l-697661 and AIDS Seroconversion
Article | Year |
---|---|
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Benzoxazoles; beta 2-Microglobulin; Biomarkers; CD4 Antigens; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; HIV Core Protein p24; HIV Seropositivity; HIV-1; Humans; Male; Neoplasms; Pyridones; Time Factors; Viremia; Zidovudine | 1993 |
Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.
Topics: Adult; Antipyrine; Antiviral Agents; Base Sequence; Benzoxazoles; Cross-Over Studies; DNA Primers; DNA, Viral; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Genes, pol; Genotype; HIV Seropositivity; HIV-1; Humans; Male; Molecular Sequence Data; Pilot Projects; Pyridones; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |